Is erythromycin lactobionate exposure in infancy associated with an increased risk of infantile hypertrophic pyloric stenosis?

Epidemiological studies suggest erythromycin lactobionate exposure in infancy is associated with a 2–3-fold increased risk of infantile hypertrophic pyloric stenosis, highest following exposure during the first 14 days of life.